A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS)

Journal article

Peer reviewed

Prasad Nishtala, Teyuan Chyou and Department of Life Sciences

Drug Safety, Vol.43(6), pp.607-609

04/04/2020

Handle:

https://hdl.handle.net/10523/36701

Abstract

Pharmacology

Pharmacology (medical)

Toxicology

7 Record Views

Record Identifier: 9926529298001891
Title: A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS)
Creators: Prasad Nishtala
Teyuan Chyou
Department of Life Sciences
Publication Details: Drug Safety, Vol.43(6), pp.607-609
Academic Unit: Medicine (UOC); Biochemistry
Date published ; e-published: 04/04/2020
Language: English
Resource Type ; Subtype: Journal article